We tested for statistically significant associations with tumor characteristics such as molecular subtype, grade, stage, vascular invasion, ER status, Nottingham Prognostic Index (NPI) as well as TP53 status as determined by mutation screening and HER2 status assessed by immunohistochemistry (unpublished results). The gene discussed is ERBB2; the disease is neoplasm.